Results 161 to 170 of about 286,424 (258)

Woodchuck and deer Hepatitis Delta-like agents show distinct innate immune activation and IFN-resistance compared to human Hepatitis D Virus. [PDF]

Sci Rep
Gnouamozi GE, Kooij AC, Schrimpf MR, Zehnder B, Zhang Z, Urban S.   +5 more
europepmc   +1 more source

Long-Term Post-transplant Outcomes in Patients with Hepatitis D Virus Infection at a High-Volume Liver Transplant Center. [PDF]

Dig Dis Sci
Keser MF, Keser ZB, Yurdaydin C, Yilmaz S, Harputluoglu M.   +4 more
europepmc   +1 more source

Sequence diversity of hepatitis D virus in Mongolia. [PDF]

Front Med (Lausanne), 2023
Magvan B, Kloeble AA, Ptok J, Hoffmann D, Habermann D, Gantumur A, Paluschinski M, Enebish G, Balz V, Fischer JC, Chimeddorj B, Walker A, Timm J.   +12 more
europepmc   +1 more source

Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus. [PDF]

Lancet Oncol
Karagas MR, Kaldor J, Michaelis M, Muchengeti MM, Alfaiate D, Argirion I, Chen X, Cunha C, Hantz S, Koljonen V, Laude HC, Lui WO, Nevels MM, O'Brien TR, Scheurer ME, Touze A, Wiemels JL, Benbrahim-Tallaa L, de Conti A, Facchin C, Madia F, Pasqual E, Wedekind R, Aguilera-Buenosvinos I, Clifford G, Deng X, Dongoran RA, Ezzemni S, Huang Y, Suonio E, Zhai Y, Mattock H, Schubauer-Berigan MK, Kunzmann AT.   +33 more
europepmc   +1 more source

Recent treatment advances and practical management of hepatitis D virus. [PDF]

Clin Med (Lond), 2023
Olsen K, Mahgoub S, Al-Shakhshir S, Algieder A, Atabani S, Bannaga A, Elsharkawy AM.   +6 more
europepmc   +1 more source

Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D). [PDF]

Open Forum Infect Dis
Ingiliz P, Vo-Quang E, Ndow G, Lemoine M, Ceesay A, Drammeh S, Hilleret MN, Bordy L, Decaens T, Mazialivoua AL, Shimakawa Y, Touray AB, Pawlotsky JM, Chemin I, Chevaliez S, Leroy V.   +15 more
europepmc   +1 more source

Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment. [PDF]

J Virol
Ding Y, Li Q, Sha Y, Si R, Feng C, Liu M, Feng Z, Ding X, Li Y, Fu H, Liang S, Yao Q, Zhang Z, Li F, Urban S, Guo H, Wang W.   +16 more
europepmc   +1 more source

Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany. [PDF]

Infection
Elamouri F, Lutz T, Knecht G, Wyen C, Posdzich P, Monin M, Sabranski M, Hoffmann C, Killer A, Jensen BE, Malin JJ, Esser S, Mauss S, Vogelmann R, Boesecke C, Beer D, Grunwald S, Haberl A, Voit F, Qurishi N, Noe S, Khaykin P, Schneeweiß SM, Christensen S, Schwarze-Zander C, Jessen A, Boyd A, Rockstroh JK, van Bremen K.   +28 more
europepmc   +1 more source

Hepatitis B virus and hepatitis D virus co-infection complicated by autoimmune hepatitis: Two case reports. [PDF]

World J Clin Cases
Dou J, Zhao XY, Wang ZG, Ning ZH, Wang XZ, Guo F.   +5 more
europepmc   +1 more source

Current and future therapeutic options for chronic hepatitis D virus infection. [PDF]

Front Cell Infect Microbiol
Pisaturo M, Russo A, Grimaldi P, Martini S, Coppola N.   +4 more
europepmc   +1 more source